Taylor Wessing advising on RSM UK on their simultaneous investment and acquisition. RSM UK has announced a strategic investment in and acquisition of RSM Ireland, a...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advising on RSM UK on their simultaneous investment and acquisition. RSM UK has announced a strategic investment in and acquisition of RSM Ireland, a...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising. Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics on its series C funding round. Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Graig Shipping PLC. Graig sold Idwal Marine Services, a global leader in vessel inspections, benchmarking and analysis to its management team and private...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Shield Therapeutics plc on the deal. Shield Therapeutics plc, an AIM-listed commercial stage specialty pharmaceutical company, extended an existing convertible debt facility by $10...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics, while Kirkland & Ellis advised Patient Square Capital on the deal. Led by Patient Square Capital, and with participation from additional...
You must be a Standard 1 Year member to access this content.
